Concord Medical Services ADRs Climb After Chinese Hospital Unit Gets New License

By MarketWatch | Sep 16, 2024 at 02:51 PM EST

Concord Medical Services' stock surged 11% to $5.61 after its subsidiary received a major medical equipment license in China. The company, focused on cancer care and research, will soon offer proton therapy treatment at Guangzhou Concord Cancer Center.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.